Literature DB >> 28602123

Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia.

Anita Szentpéteri1, Noémi Zsíros1, Viktória E Varga1, Hajnalka Lőrincz1, Mónika Katkó1, Ildikó Seres1, Péter Fülöp1, György Paragh1, Mariann Harangi1.   

Abstract

BACKGROUND: In hyperlipidaemic state, increased levels of myeloperoxidase (MPO) and decreased paraoxonase-1 (PON1) activity have been reported; however, their relationships with other atherosclerotic biomarkers have not been completely clarified. PATIENTS AND METHODS: Serum concentrations of lipid and inflammatory parameters, MPO levels, and PON1 activities were investigated in 167 untreated hyperlipidaemic patients with and without vascular complications and in 32 healthy controls. Additionally, levels of CD40 ligand (sCD40L) and asymmetric dimethyl arginine (ADMA), soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1, and oxidized LDL were determined.
RESULTS: We found elevated C-reactive protein (CRP), ADMA, sCD40L, sICAM-1 concentrations, and higher MPO levels in patients with vascular complications compared to those without. The PON1 arylesterase activity correlated negatively with sCD40L, ADMA, and sICAM-1 levels, respectively. In contrast, MPO concentrations showed positive correlations with sCD40L, ADMA, and sICAM-1 levels, respectively.
CONCLUSIONS: It can therefore be stated that PON1 activity and MPO level correlate strongly with the vascular biomarkers, highlighting the importance of the HDL-associated pro- and antioxidant enzymes in the development of endothelial dysfunction and atherogenesis.

Entities:  

Keywords:  Paraoxonase; asymmetric dimethyl arginine; hyperlipidaemia; myeloperoxidase; sCD40 ligand; soluble intercellular adhesion molecule-1

Mesh:

Substances:

Year:  2017        PMID: 28602123     DOI: 10.1024/0301-1526/a000643

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  2 in total

1.  Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology.

Authors:  Monika Czókolyová; Anita Pusztai; Edit Végh; Ágnes Horváth; Anita Szentpéteri; Attila Hamar; Szilvia Szamosi; Katalin Hodosi; Andrea Domján; Sándor Szántó; György Kerekes; Ildikó Seres; Mariann Harangi; György Paragh; Éva Szekanecz; Zoltán Szekanecz; Gabriella Szűcs
Journal:  Biomolecules       Date:  2021-10-18

2.  Renal Fibrosis Is Significantly Attenuated Following Targeted Disruption of Cd40 in Experimental Renal Ischemia.

Authors:  Shungang Zhang; Joshua D Breidenbach; Fatimah K Khalaf; Prabhatchandra R Dube; Chrysan J Mohammed; Apurva Lad; Stanislaw Stepkowski; Terry D Hinds; Sivarajan Kumarasamy; Andrew Kleinhenz; Jiang Tian; Deepak Malhotra; David J Kennedy; Christopher J Cooper; Steven T Haller
Journal:  J Am Heart Assoc       Date:  2020-03-21       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.